This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
rsi: Archive
Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Outset Medical, Inc. (OM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
OMPositive Net Change
rsi stock-price-movement
PMV Pharmaceuticals, Inc. (PMVP) Loses -70.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for PMV Pharmaceuticals, Inc. (PMVP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PMVPPositive Net Change
rsi stock-price-movement
Here's Why Holley Inc. (HLLY) is Poised for a Turnaround After Losing -18.96% in 4 Weeks
by Zacks Equity Research
Holley Inc. (HLLY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
HLLYPositive Net Change
rsi stock-price-movement
Down -21.98% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround
by Zacks Equity Research
Insulet (PODD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
PODDPositive Net Change
rsi stock-price-movement
Down -37.74% in 4 Weeks, Here's Why Vera Therapeutics, Inc. (VERA) Looks Ripe for a Turnaround
by Zacks Equity Research
Vera Therapeutics, Inc. (VERA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
VERAPositive Net Change
rsi stock-price-movement
Down -36.49% in 4 Weeks, Here's Why You Should You Buy the Dip in Nuvectis Pharma, Inc. (NVCT)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Nuvectis Pharma, Inc. (NVCT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
NVCTPositive Net Change
rsi stock-price-movement
Down -16.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Colliers International (CIGI)
by Zacks Equity Research
Colliers International (CIGI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CIGINegative Net Change
rsi stock-price-movement
Down -16.07% in 4 Weeks, Here's Why American Water Works (AWK) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for American Water Works (AWK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
AWKNegative Net Change
rsi stock-price-movement
Down -9.63% in 4 Weeks, Here's Why Boston Beer (SAM) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Boston Beer (SAM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SAMNegative Net Change
rsi stock-price-movement
Asure Software Inc (ASUR) Loses -24.36% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Asure Software Inc (ASUR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ASURPositive Net Change
rsi stock-price-movement
Inogen (INGN) Loses -24.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Inogen (INGN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
INGNPositive Net Change
rsi stock-price-movement
Down -14.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Colliers International (CIGI)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Colliers International (CIGI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
CIGINegative Net Change
rsi stock-price-movement
Insulet (PODD) Loses -24.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Insulet (PODD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
PODDPositive Net Change
rsi stock-price-movement
Down -33.71% in 4 Weeks, Here's Why ElectraMeccanica Vehicles Corp. (SOLO) Looks Ripe for a Turnaround
by Zacks Equity Research
ElectraMeccanica Vehicles Corp. (SOLO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SOLOPositive Net Change
rsi stock-price-movement
Down -19.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Immatics (IMTX)
by Zacks Equity Research
Immatics (IMTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
IMTXPositive Net Change
rsi stock-price-movement
Here's Why Keurig Dr Pepper, Inc (KDP) is Poised for a Turnaround After Losing -11.59% in 4 Weeks
by Zacks Equity Research
The heavy selling pressure might have exhausted for Keurig Dr Pepper, Inc (KDP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
KDPNegative Net Change
rsi stock-price-movement
Down -25.05% in 4 Weeks, Here's Why Repare Therapeutics Inc. (RPTX) Looks Ripe for a Turnaround
by Zacks Equity Research
Repare Therapeutics Inc. (RPTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
RPTXPositive Net Change
rsi stock-price-movement
Cardiff Oncology (CRDF) Loses -29.75% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Cardiff Oncology (CRDF) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
CRDFNo Net Change
rsi stock-price-movement
After Plunging -11.1% in 4 Weeks, Here's Why the Trend Might Reverse for Align Technology (ALGN)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Align Technology (ALGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ALGNNegative Net Change
rsi stock-price-movement
Down -30.28% in 4 Weeks, Here's Why You Should You Buy the Dip in ElectraMeccanica Vehicles Corp. (SOLO)
by Zacks Equity Research
The heavy selling pressure might have exhausted for ElectraMeccanica Vehicles Corp. (SOLO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SOLOPositive Net Change
rsi stock-price-movement
Spectrum (SPB) Loses -5.12% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Spectrum (SPB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
SPBNegative Net Change
rsi stock-price-movement
ElectraMeccanica Vehicles Corp. (SOLO) Loses -30.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for ElectraMeccanica Vehicles Corp. (SOLO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SOLOPositive Net Change
rsi stock-price-movement
Down -17.48% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Insulet (PODD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PODDPositive Net Change
rsi stock-price-movement
Down -11.3% in 4 Weeks, Here's Why Keurig Dr Pepper, Inc (KDP) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Keurig Dr Pepper, Inc (KDP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
KDPNegative Net Change
rsi stock-price-movement
Down -13.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Yeti (YETI)
by Zacks Equity Research
Yeti (YETI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
YETIPositive Net Change
rsi stock-price-movement